Dr. Jiangang Duan is a distinguished neurologist and researcher at the Department of Emergency and Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China. With over two decades of clinical and academic experience, he specializes in cerebral venous thrombosis (CVT), ischemic stroke, and neuroprotective therapies. His groundbreaking work includes the development of diagnostic imaging techniques, exploration of biomarkers for venous infarcts, and innovative non-drug therapies for ischemic stroke. Dr. Duan is also a dedicated mentor and educator, shaping the next generation of neurologists through his teaching and supervision of postgraduate students. His extensive research has been published in prestigious journals, and he has contributed to the creation of national guidelines for the management of cerebrovascular diseases.

Professional Profile

• Scopus Profile

Education

Dr. Duan holds a Ph.D. and M.D. in Neurology from West China Hospital, Sichuan University (2004–2007), where his dissertation focused on the neuroprotective effects of acupuncture in ischemic stroke models. He earned an M.S. in Human Anatomy and Histoembryology from West China College of Basic and Forensic Medicine (2001–2004), researching ganglioside GM1’s role in neural stem cell differentiation. His academic journey began with a B.S. in Clinical Medicine from Inner Mongolia Medical College (1991–1996), establishing a strong foundation for his future contributions to neuroscience.

Professional Experience

Dr. Duan is an Associate Professor at the Department of Emergency and Neurology, Capital Medical University, Beijing, since 2015. His clinical and research roles involve pioneering treatment strategies for CVT and ischemic strokes. He previously served as a visiting scholar at the Chinese University of Hong Kong (2012–2013), contributing to long-term studies on cardiovascular risks in diabetic patients. Dr. Duan’s work at Xuanwu Hospital includes innovative projects like using DOACs for CVT treatment, evaluating glucocorticoid efficacy, and exploring NF-κB-NLRP3 inflammasome signaling in thrombosis pathogenesis. His efforts have significantly influenced the field of cerebrovascular disease management in China and beyond.

Research Interests

Dr. Duan’s research primarily focuses on the mechanisms and treatments of cerebrovascular disorders, particularly CVT and ischemic strokes. His interests extend to the role of inflammation in thrombosis, novel non-drug therapies for neuroprotection, and the efficacy of anticoagulants like Dabigatran in CVT management. He also investigates biomarkers, such as serum Claudin-5, for predicting venous infarcts and utilizes advanced imaging techniques like MRBTI to evaluate thrombosis stages. His translational research bridges clinical and preclinical studies, aiming to improve diagnostics, treatments, and outcomes for patients with cerebrovascular diseases.

Research Skills

Dr. Duan is proficient in advanced diagnostic imaging methods, including MRBTI, and skilled in conducting both retrospective and prospective studies. He excels in randomized controlled trials, having evaluated the safety and efficacy of anticoagulants and glucocorticoids in cerebrovascular diseases. His expertise in biomarker identification and inflammasome signaling pathways demonstrates his command of molecular and clinical neurology. Additionally, Dr. Duan is adept at statistical analysis, multidisciplinary collaboration, and guideline development, making him a leading figure in cerebrovascular research and clinical practice.

Honors and Awards

Dr. Duan has received numerous accolades, including the prestigious Chinese Medical Science and Technology Award (2019) for his work on non-drug therapies for ischemic stroke. In 2018, he was awarded a fellowship by the European Stroke Research Foundation, where he presented groundbreaking research at the 27th European Stroke Conference in Athens, Greece. He was also recognized with the Outstanding Mentor Management Award in 2021 for his exemplary guidance of postgraduate students. Earlier honors include a scholarship for master’s students at Sichuan University (2002–2003) and recognition for his contributions to cerebrovascular disease management guidelines in China.

Conclusion

Dr. Jiangang Duan is a strong contender for the Best Researcher Award. His robust track record in neurology research, impactful mentorship, and contributions to clinical practice guidelines highlight his expertise and dedication. While there is room to amplify his global impact through high-impact publications and leadership in international projects, his achievements already position him as a distinguished researcher in his field.

Publication Top Notes

1. Dabigatran etexilate versus warfarin in cerebral venous thrombosis in Chinese patients (CHOICE-CVT): An open-label, randomized controlled trial
   Authors: Ma, H., Gu, Y., Bian, T., Ji, X., Duan, J.
   Journal: International Journal of Stroke
   Year: 2024
   Volume & Pages: 19(6), pp. 635–644
   Citations: 2
2. Multicenter registry study of cerebral venous thrombosis in China (RETAIN-CH): Rationale and design
   Authors: Bian, H., Wang, X., Liu, L., Wang, L., Ji, X.
   Journal: Brain and Behavior
   Year: 2024
   Volume & Pages: 14(4), e3353
3. Night shift work was associated with functional outcomes in acute ischemic stroke patients treated with endovascular thrombectomy
   Authors: Yu, W., Ma, J., Guo, W., Zhao, W., Ji, X.
   Journal: Heliyon
   Year: 2024
   Volume & Pages: 10(4), e25916
4. Predicting Futile Recanalization in Acute Ischemic Stroke Patients Undergoing Endovascular Thrombectomy: The Role of White Blood Cell Count to Mean Platelet Volume Ratio
   Authors: Yu, W., Jia, M., Guo, W., Song, H., Ji, X.
   Journal: Current Neurovascular Research
   Year: 2024
   Volume & Pages: 21(1), pp. 6–14
5. Severe deep cerebral venous thrombosis associated with ulcerative colitis: one case report | 重 症 脑 深 静 脉 血 栓 形 成 并 溃 疡 性 结 肠 炎 一 例
   Authors: Wang, J.-B., Gu, Y.-Q., Duan, J.-G.
   Journal: Chinese Journal of Contemporary Neurology and Neurosurgery
   Year: 2024
   Volume & Pages: 24(3), pp. 193–198
6. Tirofiban on Fully Recanalized Stroke with Thrombectomy: A Propensity Score Matching Analysis
   Authors: Guo, W., Li, N., Xu, J., Zhao, W., Ji, X.
   Journal: Journal of Clinical Pharmacy and Therapeutics
   Year: 2024
   Volume & Pages: Article ID: 1171260
7. Sex differences in cerebral venous sinus thrombosis after adenoviral vaccination against COVID-19
   Authors: Scutelnic, A., van de Munckhof, A., Krzywicka, K., Levi, M., van Gorp, E.C.M.
   Journal: European Stroke Journal
   Year: 2023
   Volume & Pages: 8(4), pp. 1001–1010
   Citations: 1
8. Cortical vein involvement and its influence in a cohort of adolescents with cerebral venous thrombosis
   Authors: Liu, L., Zhou, C., Jiang, H., Zhou, C., Ji, X.
   Journal: Thrombosis Journal
   Year: 2023
   Volume & Pages: 21(1), Article 78
   Citations: 1
9. Impaired Dynamic Cerebral Autoregulation in Patients With Cerebral Venous Sinus Thrombosis: Evaluation Using Transcranial Doppler and Silent Reading Stimulation
   Authors: Chen, S., Chen, H., Duan, J., Liu, R., Xing, Y.
   Journal: Ultrasound in Medicine and Biology
   Year: 2023
   Volume & Pages: 49(10), pp. 2221–2226
10. Cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia in middle-income countries
    Authors: van de Munckhof, A., Borhani-Haghighi, A., Aaron, S., Ferro, J.M., Coutinho, J.M.
    Journal: International Journal of Stroke
    Year: 2023
    Volume & Pages: 18(9), pp. 1112–1120
    Citations: 3